Clinical Trial Update: Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

View source ↗

Summary

AstraZeneca-sponsored study in Bulgaria that investigated undertreatment of patients with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Snippet

Sponsor: AstraZeneca | Conditions: Dyslipidemia | Status: COMPLETED